Monthly Archives: August 2018

Medtronic exec: Google looms large as next great rival

May 7, 2014 by Brian Johnson Medtronic executive Dr. Stephen Oesterle thinks Google will be a force to be reckoned with in the medical technology space in coming years. As Medtronic's  (NYSE:MDT) resident technology scout and visionary, Dr. Stephen Oesterle's job is to challenge the status quo at the world's largest pure-play medical device company. This morning Oesterle's

By |2018-08-01T17:15:38+00:00August 1st, 2018|Uncategorized|

North American Spine’s AccuraScope Procedure Featured on The Doctors TV Show

DALLAS, April 8, 2015 /PRNewswire/ -- North American Spine™, the exclusive provider of the AccuraScope® Procedure, was featured on The Doctors TV Show, April 8, 2015. The segment was a follow up of a show that featured North American Spine on the program back in Dec. of 2013. Immediately after airing, North American Spine and the show received a flood of inquiries from viewers

By |2018-08-01T17:14:12+00:00August 1st, 2018|Spine|

Medtech’s ROSA Robotic Surgery System to be Featured at the 84th American Association of Neurological Surgeons (AANS) Annual Meeting

MONTPELLIER, France, April 25, 2016 (GLOBE NEWSWIRE) -- MEDTECH (Euronext, FR0010892950 – ROSA), a company specialized in designing, developing and marketing innovative surgical assistance robots, today announced that it will showcase its ROSA™ robotic surgery systems at the upcoming 84thAmerican Association of Neurological Surgeons (AANS) Annual Meeting, being held April 30 – May 4 in

By |2018-08-01T17:11:53+00:00August 1st, 2018|Robotics|

Osiris Therapeutics, Inc. to Re-list on The Nasdaq Global Market on August 1, 2018

COLUMBIA, Md., Aug. 01, 2018 (GLOBE NEWSWIRE) -- Osiris Therapeutics, Inc. (NASDAQ: OSIR), a regenerative medicine company focused on developing and marketing products for wound care, orthopedics, and sports medicine, today announced that The Nasdaq Stock Market LLC has approved its application to list its common stock on The Nasdaq Global Market. Osiris’s common stock

By |2018-08-01T17:10:24+00:00August 1st, 2018|Financial|

NuVasive Announces Second Quarter 2018 Financial Results

SAN DIEGO, July 31, 2018 /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally-integrated solutions, today announced financial results for the quarter ended June 30, 2018. Second Quarter 2018 Highlights Revenue increased 8.5% to $281.6 million, or 7.7% on a constant currency basis; GAAP operating profit margin of 10.1%;

By |2018-08-01T16:04:15+00:00August 1st, 2018|Financial|